Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes

AimGastrointestinal discomfort is the most common adverse event in metformin treatment for type 2 diabetes. The mechanism of action of metformin is associated with gut microbiota. However, the gut microbial community structure related to metformin-induced gastrointestinal adverse events remains uncl...

Full description

Bibliographic Details

Published in:	Frontiers in Endocrinology
Main Authors:	Yuxin Huang, Xudan Lou, Cuiping Jiang, Xueying Ji, Xiaoming Tao, Jiao Sun, Zhijun Bao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Subjects:	type 2 diabetes metformin gastrointestinal adverse events gut microbiota short-chain fatty acids (SCFAs)
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1044030/full